Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting1
unknown1
Withdrawn1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

not_yet_recruiting120%
unknown120%
withdrawn120%
completed120%
active_not_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

NCT07226453
active_not_recruiting

Assessing Brain Metabolism Using MRS With Deuterated Glucose

NCT06594315
unknownnot_applicable

Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency

NCT05904366
completednot_applicable

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

NCT02657135
withdrawn

Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma

NCT00760903

Clinical Trials (5)

Showing 5 of 5 trials
NCT07226453Phase 2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Not Yet Recruiting
NCT06594315

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Active Not Recruiting
NCT05904366Not Applicable

Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency

Unknown
NCT02657135Not Applicable

Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

Completed
NCT00760903

Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5